Q3 2014 13F Holders as of 30 Sep 2014
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
54.8M
-
Number of holders
-
53
-
Total 13F shares, excl. options
-
9.72M
-
Shares change
-
+740K
-
Total reported value, excl. options
-
$81.5M
-
Value change
-
+$5.57M
-
Number of buys
-
27
-
Number of sells
-
-24
-
Price
-
$8.39
Significant Holders of Cara Therapeutics, Inc. - Common Stock, par value $0.001 per share (CARA) as of Q3 2014
60 filings reported holding CARA - Cara Therapeutics, Inc. - Common Stock, par value $0.001 per share as of Q3 2014.
Cara Therapeutics, Inc. - Common Stock, par value $0.001 per share (CARA) has 53 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9.72M shares
of 54.8M outstanding shares and own 17.73% of the company stock.
Largest 10 shareholders include RHO CAPITAL PARTNERS INC (2.67M shares), FMR LLC (1.29M shares), ABERDEEN ASSET MANAGEMENT PLC/UK (890K shares), FRANKLIN RESOURCES INC (611K shares), TIVERTON ASSET MANAGEMENT LLC (400K shares), DEERFIELD MANAGEMENT CO (383K shares), JPMORGAN CHASE & CO (354K shares), WELLINGTON MANAGEMENT CO LLP (340K shares), WALL STREET ASSOCIATES (287K shares), and PRICE T ROWE ASSOCIATES INC /MD/ (254K shares).
This table shows the top 53 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.